At its meeting on August 31, the Board of Directors approved the commercial action plan for Metroselskabet for the period 2018-2022. The action plan consists of three focus areas, including the opening of the M3 line and the Nordhavn Metro. The opening and the commercial launch will be the biggest event for The Company in the next two years. The launch will focus on the time immediately before and after the opening to ensure that as many passengers as possible use the Metro system as a whole from day one.
"In the years immediately following the opening of the M3 line and the metro to Nordhavn, Metroselskabet must ensure coherence between the new lines and the existing metro. The Company must also ensure that the capital's public transport system and its customers get the full benefit of the new, coherent metro network. In this connection, customers must be helped to make easy and efficient use of the new connections between the Metro, trains and buses," says Chairman of the Board Jørn Neergaard Larsen.
In the coming years, passenger growth in the Metro as a result of population growth will put pressure on the capacity of the existing Metro, which is why Metroselskabet has allocated funds to expand capacity so that the Metro can continue to deliver high operational stability and service while maintaining the system and serving more passengers.
The Board also discussed the risk of a possible delay in the opening of the M3 line in light of the fact that there is still complicated work to be done, which is crucial in relation to the schedule. The Board reviewed the progress of the electrical installations and the layout of the stations, which are essential works ahead of the full test run. In the coming months, the Board will have extra focus on the risk of a possible delay and will closely follow and discuss the current progress.
Finally, the Board approved the information to the owners about the M3 line and decided that, going forward, reports will be made to the owners on a monthly basis on a number of measuring points.